Neurosarcoidosis during the treatment of primary Sjögren's syndrome: is it a paradoxical effect of rituximab?

Clin Exp Rheumatol. 2022 Dec;40(12):2464-2465. doi: 10.55563/clinexprheumatol/2yhllj. Epub 2022 Oct 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Central Nervous System Diseases* / diagnosis
  • Central Nervous System Diseases* / drug therapy
  • Humans
  • Rituximab / adverse effects
  • Sarcoidosis* / drug therapy
  • Sjogren's Syndrome* / diagnosis
  • Sjogren's Syndrome* / drug therapy

Substances

  • Rituximab

Supplementary concepts

  • Neurosarcoidosis